Biodesix, Inc. (BDSX) Earnings History
Annual and quarterly earnings data from 2018 to 2025
Loading earnings history...
BDSX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BDSX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 75.2% | -31.5% | -39.8% |
| 2024 | 78.2% | -48.4% | -60.2% |
| 2023 | 73.5% | -84.2% | -106.2% |
| 2022 | 63.0% | -132.4% | -171.3% |
| 2021 | 44.0% | -75.1% | -79.2% |
Download Data
Export BDSX earnings history in CSV or JSON format
Free sign-in required to download data
Biodesix, Inc. (BDSX) Earnings Overview
As of May 8, 2026, Biodesix, Inc. (BDSX) reported trailing twelve-month net income of -$32M, reflecting +29.2% year-over-year growth. The company earned $-3.31 per diluted share over the past four quarters, with a net profit margin of -39.8%.
Looking at the long-term picture, BDSX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$26M in fiscal 2018.
Biodesix, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EXAS (-$208M net income, -6.4% margin), NTRA (-$208M net income, -9.0% margin), VCYT ($88M net income, 12.8% margin), BDSX has room to improve margins relative to the peer group. Compare BDSX vs EXAS →
BDSX Earnings vs Peers
Earnings metrics vs comparable public companies
BDSX Historical Earnings Data (2018–2025)
8 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$35M | +17.9% | -$28M | $-4.67 | -39.8% | -31.5% |
| 2024 | -$43M | +17.7% | -$34M | $-6.60 | -60.2% | -48.4% |
| 2023 | -$52M | +20.3% | -$41M | $-12.80 | -106.2% | -84.2% |
| 2022 | -$65M | -51.6% | -$51M | $-31.00 | -171.3% | -132.4% |
| 2021 | -$43M | -37.7% | -$41M | $-31.60 | -79.2% | -75.1% |
| 2020 | -$31M | -2.0% | -$23M | $-6.48 | -68.8% | -50.3% |
| 2019 | -$31M | -17.4% | -$27M | $-0.67 | -125.1% | -108.9% |
| 2018 | -$26M | - | -$23M | $-19.80 | -128.1% | -114.8% |
See BDSX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDSX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDSX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBDSX — Frequently Asked Questions
Quick answers to the most common questions about buying BDSX stock.
Is BDSX growing earnings?
BDSX EPS is $-3.31, with earnings growth accelerating to +29.2%. This exceeds the 5-year CAGR of N/A. TTM net income reached $-32M.
What are BDSX's profit margins?
Biodesix, Inc. net margin is -39.8%, with operating margin at -31.5%. Below-average margins reflect competitive or cost pressures.
How consistent are BDSX's earnings?
BDSX earnings data spans 2018-2025. The accelerating earnings trend is +29.2% YoY. Historical data enables comparison across business cycles.